bioAffinity Technologies, Inc. (BIAF) Misses Q2 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts BIAF Hot Sheet
Join SI Premium – FREE
bioAffinity Technologies, Inc. (NASDAQ: BIAF) reported Q2 EPS of ($0.17), $0.07 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $1.21 million.
For earnings history and earnings-related data on bioAffinity Technologies, Inc. (BIAF) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Yum China (YUMC) Tops Q3 EPS by 3c
- BMO Capital Upgrades Marsh (MRSH) to Outperform, 'Top Broker Pick'
- Raymond James on Airbnb Inc. (ABNB) into Earnings: 'AI Founder Mode Firing Up as Fundamental Strength Likely Persists'
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
